High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

Published:2011-04-24 Issue:2 Volume:29 Page:618-626
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Liu Xiao-Guang,Zhu Wang-Yu,Huang Yan-Yan,Ma Li-Na,Zhou Shi-Quan,Wang Ye-Kai,Zeng Fang,Zhou Ji-Hang,Zhang Yong-Kui

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-011-9923-y.pdf

Reference38 articles.

1. Jemal A, et al. Cancer statistics, 2009. CA Cancer J Clinic. 2009;59:225–49.

2. Lin P, Yu S, Yang P. MicroRNA in lung cancer. British J Cancer. 2010;103:1144–8.

3. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853–8.

4. Hutvágner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science. 2002;297:2056–60.

5. Volinia S, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Nat Acad Sci USA. 2006;103:2257–61.

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review;Cancers;2024-06-26

2. microRNAs, oxidative stress, and genotoxicity as the main inducers in the pathobiology of cancer development;Hormone Molecular Biology and Clinical Investigation;2024-03-21

3. Exosome as non-invasive prognostic and diagnostic biomarker and nanovesicle for targeted therapy of non-small cell lung carcinoma;Chemical Engineering Journal;2024-01

4. MicroRNAs modulation in lung cancer: exploring dual mechanisms and clinical prospects;BIOCELL;2024

5. Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC;Discover Oncology;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3